CD274 and neoplasm: Since the PD-L1 positivity rate in SCC was higher and LC tumor driver abnormalities were rarer compared to AD, only 26% (10 out of 39) of PD-L1 positive SCC patient samples harbored one or more of the LC tumor driver gene abnormalities.